Evaluation of Lipid Profile of High Salt fed Rats treated with L-Arginine
Keywords:cardiovascular risks, dyslipidemia, L-Arginine, rats fed high salt diet
There is a global concern on salt consumption above the dietary guideline; salt consumption evokes physiological responses with cardiovascular risks associated with dyslipidemia other than increased blood pressure as numerous studies have pointed out. This study aimed at evaluating the effect of L-Arginine on lipid profile of rats fed high salt diet. Forty Male Albino Wister rats weighing between 70-120g were randomly selected assigned into four groups of 10 rats each. Group 1 served as the control and was given distilled water and normal rat chow. Group 2 was fed with high salt diet (8% Nacl in feed, and 1% Nacl in drinking water) Group 3 was treated as group 2 with the introduction of L-Arginine on the 43rd day of the experiment. Group 4 was treated as group 2 with the introduction of losartan administration on the 43rd day of the experiment. Administration of L-Arginine and losartan lasted for 14 days, making a total duration of feeding and drugs administration 56 days. At the end of the 56th day, the rats were fasted overnight for 12 hours and sacrificed under anaesthesia using sodium pentobarbitone. Blood samples were then collected from each animal via cardiac puncture into heparinized tubes and centrifuged at 3500rpm for a period of 15 min, and the clear supernatant plasma were collected and stored at -20°C for biochemical analyses of lipid profile. The results showed a significant increase in TG, LDL-C, TC, VLDL-C and a reduction of HDL-C in the salt fed group. Conversely, a significant reduction in TG, LDL-C, TC, VLDL-C and an increase in HDL-C was shown in the salt + L-Arginine treated group when compared to the control. The changes observed in the L-Arginine treated groups reversed the hyperlipidemia in the salt treated group which indicates L-Arginine is beneficial in treatment of salt induced dyslipidemia and cardiovascular diseases.
Keywords: cardiovascular risks, dyslipidemia, L-Arginine, rats fed high salt diet
Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA, Brand-Miller J. Origins and evolution of the Western diet: health implications for the 21st century, The American journal of clinical nutrition, 2005; 81(2):341-354. https://doi.org/10.1093/ajcn.81.2.341 PMid:15699220
Liebson PR, Grandits GA, Dianzumba S, Prineas RJ, Grimm Jr. RH, Neaton JD, Stamler J. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation, 1995; 91(3): 698-706. https://doi.org/10.1161/01.CIR.91.3.698 PMid:7828296
Strazzullo P, D'Elia L, Kandala NB, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. British Medical Journal; 2009:339. https://doi.org/10.1136/bmj.b4567 PMid:19934192 PMCid:PMC2782060
Richardson WJ, Clarke SA, Quinn TA, Holmes JW. Physiological Implications of Myocardial Scar Structure, Compr. Physiol, 2015; 5(4):1877-1909. https://doi.org/10.1002/cphy.c140067
Egan BM, Weder AB, Petrin J, Hoffman RG. Neurohumoral and metabolic effects of short-term dietary nacl restriction in men relationship to salt-sensitivity status. American Journal of hypertension, 1991; 4(5_Pt_1):416-421. https://doi.org/10.1093/ajh/4.5.416 PMid:1676891
Ruppert M, Overlack A, Kolloch R, Kraft K, Göbel B, Stumpe KO. (1993). Neurohormonal and metabolic effects of severe and moderate salt restriction in non-obese normotensive adults. Journal of hypertension, 1993; 11(7): 743-749. https://doi.org/10.1097/00004872-199307000-00010 PMid:8228194
Jefcoate CR, McNamara BC, Artemenko I, Yamazaki T. Regulation of cholesterol movement to mitochondrial cytochrome P450scc in steroid hormone synthesis. The Journal of Steroid Biochemistry and Molecular Biology, 1992; 43(8):751-767. https://doi.org/10.1016/0960-0760(92)90305-3 PMid:22217822
He FJ, Li J, MacGregor GA. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. British Medical Journal, 2013; 346. https://doi.org/10.1002/14651858.CD004937.pub2
Padilha BM, Ferreira RC, Bueno NB, Tassitano RM, Holanda LS, Vasconcelos SML, Cabral PC. Association between blood cholesterol and sodium intake in hypertensive women with excess weight. Medicine, 2018; 97(15): e0371. https://doi.org/10.1097/MD.0000000000010371 PMid:29642188 PMCid:PMC5908596
Harsha DW, Sacks FM, Obarzanek E, Svetkey LP, Lin PH, Bray GA, Appel LJ. Effect of dietary sodium intake on blood lipids: results from the DASH-sodium trial. Hypertension, 2004; 43(2):393-398. https://doi.org/10.1161/01.HYP.0000113046.83819.a2 PMid:14707154
Gulati K, Joshi JC, Ray A, Recent advances in stress research: Focus on nitric oxide. European Journal of Pharmacology, 2015; 765:406-414. https://doi.org/10.1016/j.ejphar.2015.08.055 PMid:26341014
Dashtabi A, Mazloom Z, Fararouei M, Hejazi N. Oral L-Arginine administration improves anthropometric and biochemical indices associated with cardiovascular diseases in obese patients: a randomized, single blind placebo controlled clinical trial. Research in Cardiovascular Medicine, 2016; 5(1). https://doi.org/10.5812/cardiovascmed.29419 PMid:26889456 PMCid:PMC4750008
Zhoa YX, Tong L, Zhang GM, Zhao XH, Sa YP, Liu Y, Lu DX, Ga Q, Wu PL. Arginine supplementation improves vascular endothelial dysfunction induced by high fat diet in rats exposed to hypoxia. Wilderness Environmental Medicine, 2020; 31:400-406. https://doi.org/10.1016/j.wem.2020.06.010 PMid:33132032
Bogdanski P, Suliburska J, Szulinka M, Sikora M, Walkowsiak J,Jakubowski HL. L-Arginine and vitamin C attenuate pro-atherogenic effects of high-fat diet on biomarkers of endothelial dysfunction in rats. Biomedical Pharmacotherapy, 2015:76:100-106. https://doi.org/10.1016/j.biopha.2015.10.001 PMid:26653556
Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG. Animal research: reporting in vivo experiments-the ARRIVE guidelines. Journal of Cerebral Blood Flow & Metabolism, 2011; 31(4):991-993. https://doi.org/10.1038/jcbfm.2010.220 PMid:21206507 PMCid:PMC3070981
Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clinical chemistry, 1982; 28(10):2077-2080. https://doi.org/10.1093/clinchem/28.10.2077 PMid:6812986
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical chemistry, 1972; 18(6): 499-502. https://doi.org/10.1093/clinchem/18.6.499 PMid:4337382
Berger, S. (1976). Fundamentals of Clinical Chemistry. Ed. Nobert W. Tietz. Philadelphia, W. B. Saunders, 2nd edition.
Mukuddem-Petersen J, Oosthuizen, W, Jerling JC. A systematic review of the effects of nuts on blood lipid profiles in humans. The Journal of Nutrition, 2005; 135(9):2082-2089. https://doi.org/10.1093/jn/135.9.2082 PMid:16140880
Valenzuela A, Sanhueza J, Nieto S. Cholesterol oxidation: Health hazard and the role of antioxidants in prevention, Biological Research; 2013; 36:3-6. https://doi.org/10.4067/S0716-97602003000300002
Mader SS. Inquiry into life. Septième edition. WMC Brown publishers. Dubique, lowa. Melbourne Australie. England, pp: 369- 391, 1994.
Poirier P. Obesity and cardiovascular disease: patho-physiology, evaluation, and effect of weight loss. Circulation, 2006; 113: 898-918 https://doi.org/10.1161/CIRCULATIONAHA.106.171016 PMid:16380542
Lucotti P, Setola E, Monti LD, Galluccio E, Costa S, Sandoli EP, Comi GC. Beneficial effects of a long-term oral L-Arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients. The American Journal of Physiology-Endocrinology and Metabolism, 2002; 283(2):E332-E339.
Mackness MI, Arrol S, Durrington PN, Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. (1991). FEBS Letters,1991; 286(1-2):152-154. https://doi.org/10.1016/0014-5793(91)80962-3 PMid:1650712
Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD. High-density lipoprotein cholesterol and cardiovascular disease: Four prospective American studies. Circulation, 1989; 79(1): 8-15. https://doi.org/10.1161/01.CIR.79.1.8 PMid:2642759
Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal, R. S., Yancy CW 2018, AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019; 73:e285-e350 https://doi.org/10.1016/j.jacc.2018.11.003 PMid:30423393
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Landmesser U. 2019ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. European Heart Journal, 2019; 41(1):111-188. https://doi.org/10.1093/eurheartj/ehz455 PMid:31504418
Monti LD, Setola E, Lucotti P, Marrocco-Trischitta MM, Comola M, Galluccio E, Pontiroli AE. Effect of a long-term oral L-Arginine supplementation on glucose metabolism: A randomized, double-blind, placebo-controlled trial. Diabetes, Obesity and Metabolism, 2002; 4(2):96-105.
Dong JY, Qin LQ, Zhang Z, Zhao YY, Wang J. Ar-ginine supplementation and metabolic diseases: A systematic review of randomized controlled trials. The Journal of Nutrition, 2016; 146(11): 2239S-2246S.
How to Cite
Copyright (c) 2023 Justin Atiang Beshel, Justina Andornimye Ashipu, Paulicarp Umim Adie, Favour Nyoh Beshel, Gabriel Otu Ujong
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.